Abstract
The adult central nervous system (CNS) contains a population of neural stem cells, yet unlike many other tissues, has a very limited capacity for self-repair. Promoting tissue repair and functional recovery following CNS injury or disease is a high priority as there are currently no effective treatments towards this end for the treatment of disorders such as stroke, traumatic brain injury and spinal cord injury. Recent advances in stem cell biology have offered a number of enticing potential avenues and we will discuss these possibilities along with the associated challenges as they pertain to stroke. We will consider exogenous therapies involving the transplantation of adult stem cells, and the mobilization of endogenous stem cells, as well as drug delivery and tissue engineering strategies that enhance and complement the cell based strategies.
Keywords: Adult stem cells, neural regeneration, biomaterials, tissue engineering, drug delivery systems, stroke, central nervous system, traumatic brain injury, spinal cord injury, Surgery
Current Stem Cell Research & Therapy
Title: Adult Stem Cells and Bioengineering Strategies for the Treatment of Cerebral Ischemic Stroke
Volume: 6 Issue: 3
Author(s): Fenggang Yu and Cindi M. Morshead
Affiliation:
Keywords: Adult stem cells, neural regeneration, biomaterials, tissue engineering, drug delivery systems, stroke, central nervous system, traumatic brain injury, spinal cord injury, Surgery
Abstract: The adult central nervous system (CNS) contains a population of neural stem cells, yet unlike many other tissues, has a very limited capacity for self-repair. Promoting tissue repair and functional recovery following CNS injury or disease is a high priority as there are currently no effective treatments towards this end for the treatment of disorders such as stroke, traumatic brain injury and spinal cord injury. Recent advances in stem cell biology have offered a number of enticing potential avenues and we will discuss these possibilities along with the associated challenges as they pertain to stroke. We will consider exogenous therapies involving the transplantation of adult stem cells, and the mobilization of endogenous stem cells, as well as drug delivery and tissue engineering strategies that enhance and complement the cell based strategies.
Export Options
About this article
Cite this article as:
Yu Fenggang and M. Morshead Cindi, Adult Stem Cells and Bioengineering Strategies for the Treatment of Cerebral Ischemic Stroke, Current Stem Cell Research & Therapy 2011; 6 (3) . https://dx.doi.org/10.2174/157488811796575341
DOI https://dx.doi.org/10.2174/157488811796575341 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Brain Inflammation Following Intracerebral Hemorrhage
Current Neuropharmacology Cerebral Palsy: Classification, Etiology and Evolution of Spine Deformity in Children and Adolescents
Current Pediatric Reviews Intravitreal Inserts of Steroids to Treat Diabetic Macular Edema
Current Diabetes Reviews Area, Age and Gender Dependence of the Nucleoside System in the Brain: a Review of Current Literature
Current Topics in Medicinal Chemistry Neurotrophic Factors in Parkinson’s Disease: What Have we Learned from Pre-Clinical and Clinical Studies?
Current Medicinal Chemistry Drug Therapy of Neuropathic Pain: Current Developments and Future Perspectives
Current Drug Targets BMI1 Regulation of Self-Renewal and Multipotency in Human Mesenchymal Stem Cells
Current Stem Cell Research & Therapy Calcium Sensitizers in Cardiac Surgery: Who, When, How and Why?
Current Vascular Pharmacology New Therapeutic Applications of Phosphodiesterase 5 Inhibitors (PDE5-Is)
Current Medicinal Chemistry Nocistatin: Milestone of One Decade of Research
Current Pharmaceutical Design Increasing Expression of Heme Oxygenase-1 by Proteasome Inhibition Protects Astrocytes from Heme-mediated Oxidative Injury
Current Neurovascular Research Dimethyl Sulfoxide as an Excitatory Modulator and its Possible Role in Cancer Pain Management
Inflammation & Allergy - Drug Targets (Discontinued) Neuroserpin in Bipolar Disorder
Current Topics in Medicinal Chemistry Effects of α7 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator on BDNF, NKCC1 and KCC2 Expression in the Hippocampus following Lipopolysaccharide-Induced Allodynia and Hyperalgesia in a Mouse Model of Inflammatory Pain
CNS & Neurological Disorders - Drug Targets Therapeutic Approaches Targeting Pathological Tau Aggregates
Current Pharmaceutical Design A Hypothesis for Regenerative Therapy for Neuronal Disease: Stem Cells within Artificial Niche
Current Signal Transduction Therapy NMR in Metabolic Profiles of Neural Stem/Progenitor Cells: Current Status and Relevant Problems
Current Medical Imaging Insights into the Role of Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Health and Disease
Current Chemical Biology Editorial [Hot Topic: Gene Therapy Approaches for Neuroregeneration (Guest Editor: Kirsten Haastert-Talini)]
Current Gene Therapy Compartmentalized Platforms for Neuro-Pharmacological Research
Current Neuropharmacology